Header image

Concurrent Session 2A: Opioid Prescribing: Diversity and Access

Tracks
.
Monday, November 9, 2026
3:30 PM - 5:00 PM

Speaker

A/Prof Thileepan Naren
Addiction Medicine Specialist
Western Health

Expanding opioid agonist therapy delivery in regional Australia: a novel telehealth service

3:35 PM - 3:45 PM

Abstract PDF

Biography

A/Prof Thileepan Naren is an Addiction Medicine Specialist and General Practitioner who works at Western Health and cohealth. He has special interests in addiction medicine, Aboriginal health, custodial health, public health policy, and medical governance.
Miss Ellie Kotkis
Project Officer
East Metropolitan Health Service

Naloxone administration in emergency department presentations with suspected opioid toxicity: What proportion have analytically confirmed opioid exposure?

3:45 PM - 3:55 PM

Abstract PDF

Biography

Project Officer for the Emerging Drugs Network of Australia.
Dr Ali Cheetham
Research Fellow
Monash Addiction Research Centre, Monash University

Validating the pharmacist review summary as an outcome measurement tool in opioid dependence treatment: A secondary analysis of the EPIC-MATOD trial

3:55 PM - 4:05 PM

Abstract PDF

Biography

Research Fellow at the Monash Addiction Research Centre and Hamilton Centre, the Victorian statewide service for people living with mental illness and addiction. My research interests include improving access to evidence-based treatment for opioid dependence and co-occurring conditions, and encompasses implementation trials, co-design, health service partnerships, and workforce development.
Agenda Item Image
Ms Amy McNeilage
PhD Candidate
The University of Sydney

“We’re not stupid, we’re just doing the best we can”: Australian GP perspectives on gabapentinoid prescribing, non-medical use, and dependence

4:05 PM - 4:15 PM

Abstract PDF

Biography

Amy McNeilage is a PhD candidate and Research Officer in The University of Sydney’s Medical School with expertise in qualitative methodology. Her research seeks to identify and mitigate harms associated with gabapentinoid use.
Dr Stella Stolk
Senior Research And Policy Fellow
Community Restorative Centre

An outreach based AOD Care model for people transitioning out of Prison.

4:15 PM - 4:25 PM

Abstract PDF

Biography

Jermaine Sakr is the acting manager for the AOD transition programs at Community Restorative Centre. Stella Stolk is a Senior Research & Policy Fellow with the Advocacy, Research and Policy Unit at Community Restorative Centre. She is also an adjunct fellow at NDARC, UNSW.
Professor Adrian Dunlop
Director, Senior Staff Specialist, Drug & Alcohol Clinical Servcies
Hunter New England Local Health District

Substance use and health outcomes following release from custody: the Release study

4:25 PM - 4:35 PM

Abstract PDF

Biography

Adrian Dunlop has 30+ years’ experience as a drug & alcohol clinician/researcher. He Director and Addiction Medicine Senior Staff Specialist with Hunter New England Local Health District, and Conjoint Professor with the School of Medicine and Public Health, University of Newcastle and a member of the Hunter Medical Research Institute.
Dr Amanda Roxburgh
Senior Research Fellow
Burnet Institute

The impact of regulatory changes to pharmaceutical opioid prescribing on opioid mortality in Australia

3:35 PM - 3:45 PM

Abstract PDF

Biography

Dr Amanda Roxburgh has over 20 years experience in the AOD research sector, with expertise in drug-related harms including mortality and supervised injecting facilities.
Mr Zachary Lloyd
PhD candidate
Burnet Institute

Changes in the geographic distribution of opioid-related deaths in Australia: Exploratory Spatial Data Analysis

4:45 PM - 4:50 PM

Abstract PDF

Biography

Zachary is a PhD student with Monash University and the Burnet Institute. His research focuses on social, geographic and economic factors associated with fatal opioid overdose.
loading